Lupus erythematosus-like disease due to hydrazine
- 31 August 1983
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 75 (2) , 365-370
- https://doi.org/10.1016/0002-9343(83)91219-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamideThe American Journal of Cardiology, 1980
- Acetylator phenotype in idiopathic systemic lupus erythematosusArthritis & Rheumatism, 1980
- HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITYPublished by Elsevier ,1980
- Antibodies to Nuclear Antigens in Patients Treated with Procainamide or AcetylprocainamideNew England Journal of Medicine, 1979
- Remission of Procainamide-Induced Lupus Erythematosus with N-Acetylprocainamide TherapyAnnals of Internal Medicine, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978
- Clinical consequences of polymorphic acetylation of basic drugsClinical Pharmacology & Therapeutics, 1977
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977
- Acetylator Phenotype in Patients with Hydralazine‐induced Lupoid SyndromeActa Medica Scandinavica, 1976
- Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritisThe American Journal of Medicine, 1973